Lixte Biotechnology expects NOMAD acquisition to close around July 1, 2026

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc.

LIXT

0.00
  • Lixte Biotechnology plans to buy 100% of NOMAD Transportable Power Systems, targeting a close on or about July 1, 2026.
  • USD 6.5 million pre-closing loan to NOMAD to fund long-lead components, support working capital, and help convert backlog into deliveries.
  • Post-close, the combined company is set to be renamed NOMAD Power Solutions and trade on Nasdaq under a new ticker.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lixte Biotechnology Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606180830PRIMZONEFULLFEED9748604) on June 18, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.